Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natalie Gaughan"'
Autor:
Jennifer S. Lawton, Cecillia Lui, Sean Kearney, Natalie Gaughan, Alejandro Suarez-Pierre, Rosmi Thomas, Melissa Jones, Brian C. Cho, Thomas S. Metkus, Mary Beth Brady, Jie Wang, Xun Zhou, Jeffrey M. Dodd-o
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 163:e385-e400
Adenosine triphosphate potassium sensitive channels provide endogenous myocardial protection via coupling of cell membrane potential to myocardial metabolism. Adenosine triphosphate potassium sensitive channel openers, such as diazoxide, mimic ischem
Publikováno v:
AORTA Journal
Medionecrosis and medial degeneration are rare complications associated with intramural hematomas (IMHs). We present a case of a 69-year-old Asian female with an IMH with medionecrosis and medial degeneration of the aortic wall. The patient underwent
Cardiac ochronosis is a rare disease, estimated to affect 1 in 250,000 persons. While there is extensive evidence of the musculoskeletal alterations of the disease, cardiac involvement has not been widely studied and most information we currently hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685c8b03fa25b240672c0d528ed1eccf
https://doi.org/10.22541/au.162039025.55479465/v1
https://doi.org/10.22541/au.162039025.55479465/v1
Autor:
Rosmi Thomas, Alex Suarez-Pierre, Jennifer S. Lawton, Jie Wang, Joseph K. Canner, Natalie Gaughan, Murphy Mike, Krisztian Sebestyen
Publikováno v:
Circulation. 142
Introduction: Adenosine triphosphate-sensitive potassium (K ATP ) channel opener diazoxide (DZX) and Antioxidant MitoSNO are both independently cardioprotective in animal models. The cardioprotective mechanism of diazoxide is unknown, and involves a
Autor:
Dean Follmann, Michel C. Nussenzweig, Malcolm A. Martin, Michael S. Seaman, Natalie Gaughan, Bruce J. Swihart, Yoshiaki Nishimura, Alicia Buckler-White, Till Schoofs, Anna Gazumyan, Rajeev Gautam
Publikováno v:
Nature Medicine. 24:610-616
In the absence of an effective and safe vaccine against HIV-1, the administration of broadly neutralizing antibodies (bNAbs) represents a logical alternative approach to prevent virus transmission. Here, we introduced two mutations encoding amino aci